共 50 条
- [21] Molecular profiling of newly diagnosed multiple myeloma.BLOOD, 2001, 98 (11) : 733A - 733AZhan, FHHardin, JBumm, KZheng, MZTian, EMCrowley, JTricot, GBarlogie, BShaughnessy, J
- [22] Combination therapy with thalidomide plus dexamethasone for newly diagnosed myelomaJOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (21) : 4319 - 4323Rajkumar, SVHayman, SGertz, MADispenzieri, ALacy, MQGreipp, PRGeyer, SIturria, NFonseca, RLust, JAKyle, RAWitzig, TE
- [23] A randomized, double-blind, placebo-controlled trial of thalidomide plus dexamethasone versus dexamethasone alone as primary therapy for newly diagnosed multiple myeloma.BLOOD, 2006, 108 (11) : 238A - 238ARajkumar, S. VincentHussein, MohamadCatalano, JohnJedrzejcak, WieslawSirkovich, SvetlanaOlesnyckyj, MartaYu, ZhinuanKnight, RobertZeldis, JerryBlade, Joan
- [24] Superiority of Lenalidomide-Dexamethasone Versus Thalidomide-Dexamethasone as Initial Therapy for Newly Diagnosed Multiple MyelomaBLOOD, 2009, 114 (22) : 1494 - 1495Gay, FrancescaHayman, SuzanneLacy, Martha Q.Buadi, FrancisGertz, Morie A.Kumar, ShajiDispenzieri, AngelaMikhael, Joseph R.Bergsagel, LeifDingli, DavidReeder, Craig B.Lust, John A.Russel, StephenRoj, VivekZeldenrust, Steven R.Witzig, Thomas E.Fonseca, RafaelKyle, RobertGreipp, Philip R.Stewart, A. KeithRajkumar, S. Vincent
- [25] EFFECT OF THALIDOMIDE-DEXAMETHASONE THERAPY ON BONE MARROW ANGIOGENESIS IN NEWLY DIAGNOSED MULTIPLE MYELOMAHAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 512 - 512Ladeb, S.Mrad, K.Abdelkefi, A.Torjemane, L.Safra, I.Hdiji, S.Ben Romdhane, N.Mdhaffer, M.El Omri, H.Ben Othman, T.Ben Romdhane, K.Ben Abdeladhim, A.
- [26] Clinical Study of Thalidomide Combined with Dexamethasone for the Treatment of Elderly Patients with Newly Diagnosed Multiple MyelomaASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (09) : 4777 - 4781Chen, Hai-FeiLi, Zheng-YangTang, Jie-QingShen, Hong-ShiCui, Qing-YaRen, Yong-YaQin, Long-MeiJin, Ling-JuanZhu, Jing-JingWang, JingDing, JieWang, Ke-YuanYu, Zi-QiangWang, Zhao-YueWu, Tian-Qin
- [27] Subcutaneous Administration of Bortezomib in Combination with Thalidomide and Dexamethasone for Treatment of Newly Diagnosed Multiple Myeloma PatientsBIOMED RESEARCH INTERNATIONAL, 2015, 2015Wu, ShenghaoZheng, CuipingChen, SongyanCai, XiaopingShi, YuejianLin, BijingChen, Yuemiao
- [28] Induction Treatment With Cyclophosphamide, Thalidomide, and Dexamethasone in Newly Diagnosed Multiple Myeloma: A Phase II StudyCLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2010, 10 (01): : 62 - 67Yang, Deok-HwanKim, Yeo-KyeoungSohn, Sang-KyunChung, Joo-SeopJoo, Young-DonLee, Jae-HoonLee, Jung-LimAhn, Jae-SookMoon, Joon-HoShin, Ho-JinChoi, Young-JinLee, Won-SikKim, Hyeoung-JoonLee, Je-Jung
- [29] Efficacy and safety of thalidomide and dexamethasone combination with or without cyclophosphamide in patients with newly diagnosed multiple myelomaHAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 411 - 412Kim, Y.-K.Lee, J. J.Sohn, S. K.Shin, H. J.Lee, S. R.Shim, H. J.Ahn, J. S.Kim, D. H.Yang, D. H.Cho, S. H.Chung, I. J.Kim, H. J.
- [30] Bortezomib in combination with dexamethasone and subsequent thalidomide for newly-diagnosed multiple myeloma in Chinese patientsBLOOD, 2007, 110 (11) : 281B - 281BCai, ZhenZheng, WeiyanWei, GuoqingYe, XiujinHe, JingsongLi, LiWu, WenjunLin, Maofang